Displaying 641 - 660 of 4000
Statement of Commissioner Christine S. Wilson Regarding the Combatting Online Harms Through Innovation Report
Regarding the Combatting Online Harms Through Innovation Report
Date
Matter Number
P214501
By
Christine S. Wilson, Former Commissioner
Statement of Commissioner Rebecca Kelly Slaughter Regarding the Policy Statement of the Federal Trade Commission on Rebates and Fees in Exchange for Excluding Lower-Cost Drug Products
Regarding the Policy Statement of the Commission on Rebates and Fees in Exchange for Excluding Lower-Cost Drug Prices
Date
Matter Number
P221201
By
Rebecca Kelly Slaughter, Former Commissioner
Remarks of Chair Lina M. Khan Regarding Policy Statement on Rebates and Fees in Exchange for Excluding Lower-Cost Drug Products
Washington D.C.
Date
By
Lina M. Khan, Former Chair and Commissioner
Oral Remarks of Christine S. Wilson at Open Commission Meeting on June 16, 2022
Date
By
Christine S. Wilson, Former Commissioner
Statement of Commissioner Alvaro M. Bedoya Regarding the Commission's Policy Statement on Rebates and Fees in Exchange for Excluding Lower-Cost Drug Products
Regarding the Commission's Rebate Policy Statement
Date
Matter Number
P221201
By
Alvaro Bedoya, Former Commissioner
Remarks of Chair Lina M. Khan Regarding Combatting Online Harms Through Innovation Report
Washington D.C.
Date
By
Lina M. Khan, Former Chair and Commissioner
Statement of Commissioner Rebecca Kelly Slaughter Regarding the Commission's Report to Congress: Combatting Online Harms Through Innovation
Regarding the Combatting Online Harms Through Innovation Report to Congress
Date
Matter Number
P214501
By
Rebecca Kelly Slaughter, Former Commissioner
Statement of Commissioner Alvaro M. Bedoya Regarding Report to Congress on Combatting Online Harms Through Innovation
Regarding Report to Congress on Combatting Online Harms Through Innovation
Date
Matter Number
P214501
By
Alvaro Bedoya, Former Commissioner
Remarks of Commissioner Christine S. Wilson: An Update on Merger Enforcement
At the International Bar Association's 19th Annual International Mergers and Acquisitions Conference
New York, NY
Date
Matter Number
P180200
By
Christine S. Wilson, Former Commissioner
Keynote Remarks of Commissioner Rebecca Kelly Slaughter at the FTC/DOJ Pharmaceutical Task Force Workshop
Washington, D.C.
Date
By
Rebecca Kelly Slaughter, Former Commissioner
Statement of Chair Lina M. Khan, Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya Regarding JAB Consumer Fund/SAGE Veterinary Partners
In the Matter of JAB Consumer Fund/SAGE Veterinary Partners
Date
Matter Number
211 0140
Docket Number
C-4766
By
Lina M. Khan, Former Chair and Commissioner;
Rebecca Kelly Slaughter, Former Commissioner;
Alvaro Bedoya, Former Commissioner
Concurring Statement of Commissioners Noah Joshua Phillips and Christine S. Wilson
In the Matter of JAB Consumer Partners SCA SICAR/SAGE Veterinary Partners, LLC
Date
Matter Number
211 0140
Docket Number
C-4766
By
Noah Joshua Phillips, Former Commissioner;
Christine S. Wilson, Former Commissioner
File
Statement of Chair Lina M. Khan, Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya Regarding JAB Consumer Fund/SAGE Veterinary Partners
In the Matter of JAB Consumer Fund/SAGE Veterinary Partners
Date
Matter Number
211 0140
Docket Number
C-4766
By
Lina M. Khan, Former Chair and Commissioner;
Rebecca Kelly Slaughter, Former Commissioner;
Alvaro Bedoya, Former Commissioner
Concurring Statement of Commissioners Noah Joshua Phillips and Christine S. Wilson
In the Matter of JAB Consumer Partners SCA SICAR/SAGE Veterinary Partners, LLC
Date
Matter Number
211 0140
Docket Number
C-4766
By
Noah Joshua Phillips, Former Commissioner;
Christine S. Wilson, Former Commissioner
File
Statement of Chair Lina M. Khan, Joined by Commissioner Rebecca Kelly Slaughter and Commissioner Alvaro M. Bedoya Regarding JAB Consumer Fund/SAGE Veterinary Partners
In the Matter of JAB Consumer Fund/SAGE Veterinary Partners
Date
Matter Number
211 0140
Docket Number
C-4766
By
Lina M. Khan, Former Chair and Commissioner;
Rebecca Kelly Slaughter, Former Commissioner;
Alvaro Bedoya, Former Commissioner
SEPs and FRAND at the FTC and ITC: Current Policy Proposals and Respect for IP Rights
Date
By
Christine S. Wilson, Former Commissioner
Statement of Chair Lina M. Khan Regarding 6(b) Study of Pharmacy Benefit Managers
Date
By
Lina M. Khan, Former Chair and Commissioner
Related Releases
Displaying 641 - 660 of 4000
Pagination
Join us at the FTC!